Chan-Young Ock

Chan-Young Ock is the current Chief Medical Officer of Oncology Group at Lunit. Prior to this, they were with medpacto and theragen etex bio institute as Chief Medical Officer and Medical Director respectively. Dr. Ock has been in the medical field for over 10 years and has been instrumental in developing treatments for various cancers. Chan-Young is a highly respected figure in the medical community and their work has helped save countless lives.

Chan-Young Ock attended seoul national university for their educational career.

Chan-Young Ock reports to Beomseok Brandon Suh, CEO. They are on a team with Sunggyun Park - Co-Founder & Chief Product Officer, Radiology Group, Donggeun Yoo - Co-founder & Chief of Research, and Kyunghyun Paeng - Co-founder & Chief Product Officer-Oncology.